The Cigna Group (NYSE:CI) Shares Sold by Twin Capital Management Inc.

Twin Capital Management Inc. lessened its position in The Cigna Group (NYSE:CI) by 1.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 10,329 shares of the health services provider’s stock after selling 105 shares during the period. Twin Capital Management Inc.’s holdings in The Cigna Group were worth $3,093,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Avestar Capital LLC grew its position in The Cigna Group by 0.8% in the 3rd quarter. Avestar Capital LLC now owns 4,585 shares of the health services provider’s stock valued at $1,312,000 after buying an additional 35 shares in the last quarter. Eads & Heald Wealth Management grew its position in The Cigna Group by 1.7% in the 3rd quarter. Eads & Heald Wealth Management now owns 2,123 shares of the health services provider’s stock valued at $607,000 after buying an additional 35 shares in the last quarter. Relyea Zuckerberg Hanson LLC grew its position in The Cigna Group by 3.2% in the 4th quarter. Relyea Zuckerberg Hanson LLC now owns 1,113 shares of the health services provider’s stock valued at $333,000 after buying an additional 35 shares in the last quarter. Strategic Blueprint LLC grew its position in The Cigna Group by 4.8% in the 3rd quarter. Strategic Blueprint LLC now owns 784 shares of the health services provider’s stock valued at $224,000 after buying an additional 36 shares in the last quarter. Finally, Wambolt & Associates LLC boosted its position in shares of The Cigna Group by 1.4% during the 2nd quarter. Wambolt & Associates LLC now owns 2,536 shares of the health services provider’s stock valued at $712,000 after purchasing an additional 36 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Transactions at The Cigna Group

In related news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the firm’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the transaction, the senior vice president now owns 2,102 shares of the company’s stock, valued at $694,668.96. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the firm’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the transaction, the senior vice president now owns 2,102 shares of the company’s stock, valued at $694,668.96. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Eric P. Palmer sold 1,017 shares of the firm’s stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $335.26, for a total transaction of $340,959.42. Following the transaction, the insider now directly owns 45,564 shares in the company, valued at approximately $15,275,786.64. The disclosure for this sale can be found here. Insiders sold 114,144 shares of company stock valued at $39,296,330 over the last three months. 0.60% of the stock is owned by corporate insiders.

The Cigna Group Stock Up 0.4 %

Shares of NYSE CI traded up $1.43 during mid-day trading on Thursday, reaching $347.51. The company had a trading volume of 801,604 shares, compared to its average volume of 1,594,702. The stock has a fifty day moving average of $347.73 and a two-hundred day moving average of $314.79. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.67 and a current ratio of 0.67. The company has a market capitalization of $101.60 billion, a price-to-earnings ratio of 19.89, a PEG ratio of 1.06 and a beta of 0.56. The Cigna Group has a 12-month low of $240.50 and a 12-month high of $365.71.

The Cigna Group (NYSE:CI) last posted its quarterly earnings results on Friday, February 2nd. The health services provider reported $6.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.54 by $0.25. The business had revenue of $51.15 billion during the quarter, compared to analyst estimates of $48.91 billion. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The firm’s revenue was up 11.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $4.96 earnings per share. As a group, equities research analysts expect that The Cigna Group will post 28.36 EPS for the current year.

The Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 21st. Stockholders of record on Wednesday, March 6th were given a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.61%. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.23. The ex-dividend date of this dividend was Tuesday, March 5th. The Cigna Group’s dividend payout ratio is 32.20%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CI. Barclays began coverage on shares of The Cigna Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $393.00 price objective for the company. Wells Fargo & Company raised their price objective on shares of The Cigna Group from $334.00 to $348.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 6th. Mizuho raised their price objective on shares of The Cigna Group from $360.00 to $370.00 and gave the company a “buy” rating in a research report on Monday, February 5th. Sanford C. Bernstein upgraded shares of The Cigna Group from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $330.00 to $372.00 in a research report on Thursday, January 4th. Finally, Deutsche Bank Aktiengesellschaft raised shares of The Cigna Group from a “hold” rating to a “buy” rating and upped their price objective for the company from $355.00 to $370.00 in a research note on Thursday, February 1st. Two analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $362.14.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.